Glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in MEN1 syndrome without loss of heterozygosity at the 11q13 locus

BACKGROUND: The molecular mechanisms involved in the genesis of the adrenocortical lesions seen in MEN1 syndrome (ACL-MEN1) remain poorly understood; loss of heterozygosity at 11q13 and somatic mutations of MEN1 are not usually found in these lesions. Thus, additional genes must be involved in MEN1 adrenocortical disorders. Overexpression of the glucose-dependent insulinotropic peptide receptor has been shown to promote adrenocortical tumorigenesis in a mice model and has also been associated with ACTH-independent Cushing syndrome in humans. However, to our knowledge, the status of glucose-dependent insulinotropic peptide receptor expression in adrenocortical lesions in MEN1 has not been previously investigated. OBJECTIVE: To evaluate glucose-dependent insulinotropic peptide receptor expression in adrenocortical hyperplasia associated with MEN1 syndrome. MATERIALS/METHODS: Three adrenocortical tissue samples were obtained from patients with previously known MEN1 germline mutations and in whom the presence of a second molecular event (a new MEN1 somatic mutation or an 11q13 loss of heterozygosity) had been excluded. The expression of the glucose-dependent insulinotropic peptide receptor was quantified by qPCR using the DDCT method, and b-actin was used as an endogenous control. RESULTS: The median of glucose-dependent insulinotropic peptide receptor expression in the adrenocortical lesions associated with MEN1 syndrome was 2.6-fold (range 1.2 to 4.8) higher than the normal adrenal controls (p = 0.02). CONCLUSION: The current study represents the first investigation of glucose-dependent insulinotropic peptide receptor expression in adrenocortical lesions without 11q13 loss of heterozygosity in MEN1 syndrome patients. Although we studied a limited number of cases of MEN1 adrenocortical lesions retrospectively, our preliminary data suggest an involvement of glucose-dependent insulinotropic peptide receptor overexpression in the etiology of adrenocortical hyperplasia. New prospective studies will be able to clarify the exact role of the glucose-dependent insulinotropic peptide receptor in the molecular pathogenesis of MEN1 adrenocortical lesions.

Saved in:
Bibliographic Details
Main Authors: Costa,Marcia Helena Soares, Domenice,Sorahia, Toledo,Rodrigo Almeida, Lourenço Jr,Delmar Muniz, Latronico,Ana Claudia, Pinto,Emilia Modolo, Toledo,Sergio Pereira Almeida, Mendonca,Berenice Bilharinho, Fragoso,Maria Candida Barisson Villares
Format: Digital revista
Language:English
Published: Faculdade de Medicina / USP 2011
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000400002
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1807-59322011000400002
record_format ojs
spelling oai:scielo:S1807-593220110004000022014-01-17Glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in MEN1 syndrome without loss of heterozygosity at the 11q13 locusCosta,Marcia Helena SoaresDomenice,SorahiaToledo,Rodrigo AlmeidaLourenço Jr,Delmar MunizLatronico,Ana ClaudiaPinto,Emilia ModoloToledo,Sergio Pereira AlmeidaMendonca,Berenice BilharinhoFragoso,Maria Candida Barisson Villares MEN1 adrenocortical hyperplasia GIPR expression BACKGROUND: The molecular mechanisms involved in the genesis of the adrenocortical lesions seen in MEN1 syndrome (ACL-MEN1) remain poorly understood; loss of heterozygosity at 11q13 and somatic mutations of MEN1 are not usually found in these lesions. Thus, additional genes must be involved in MEN1 adrenocortical disorders. Overexpression of the glucose-dependent insulinotropic peptide receptor has been shown to promote adrenocortical tumorigenesis in a mice model and has also been associated with ACTH-independent Cushing syndrome in humans. However, to our knowledge, the status of glucose-dependent insulinotropic peptide receptor expression in adrenocortical lesions in MEN1 has not been previously investigated. OBJECTIVE: To evaluate glucose-dependent insulinotropic peptide receptor expression in adrenocortical hyperplasia associated with MEN1 syndrome. MATERIALS/METHODS: Three adrenocortical tissue samples were obtained from patients with previously known MEN1 germline mutations and in whom the presence of a second molecular event (a new MEN1 somatic mutation or an 11q13 loss of heterozygosity) had been excluded. The expression of the glucose-dependent insulinotropic peptide receptor was quantified by qPCR using the DDCT method, and b-actin was used as an endogenous control. RESULTS: The median of glucose-dependent insulinotropic peptide receptor expression in the adrenocortical lesions associated with MEN1 syndrome was 2.6-fold (range 1.2 to 4.8) higher than the normal adrenal controls (p = 0.02). CONCLUSION: The current study represents the first investigation of glucose-dependent insulinotropic peptide receptor expression in adrenocortical lesions without 11q13 loss of heterozygosity in MEN1 syndrome patients. Although we studied a limited number of cases of MEN1 adrenocortical lesions retrospectively, our preliminary data suggest an involvement of glucose-dependent insulinotropic peptide receptor overexpression in the etiology of adrenocortical hyperplasia. New prospective studies will be able to clarify the exact role of the glucose-dependent insulinotropic peptide receptor in the molecular pathogenesis of MEN1 adrenocortical lesions.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.66 n.4 20112011-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000400002en10.1590/S1807-59322011000400002
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Costa,Marcia Helena Soares
Domenice,Sorahia
Toledo,Rodrigo Almeida
Lourenço Jr,Delmar Muniz
Latronico,Ana Claudia
Pinto,Emilia Modolo
Toledo,Sergio Pereira Almeida
Mendonca,Berenice Bilharinho
Fragoso,Maria Candida Barisson Villares
spellingShingle Costa,Marcia Helena Soares
Domenice,Sorahia
Toledo,Rodrigo Almeida
Lourenço Jr,Delmar Muniz
Latronico,Ana Claudia
Pinto,Emilia Modolo
Toledo,Sergio Pereira Almeida
Mendonca,Berenice Bilharinho
Fragoso,Maria Candida Barisson Villares
Glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in MEN1 syndrome without loss of heterozygosity at the 11q13 locus
author_facet Costa,Marcia Helena Soares
Domenice,Sorahia
Toledo,Rodrigo Almeida
Lourenço Jr,Delmar Muniz
Latronico,Ana Claudia
Pinto,Emilia Modolo
Toledo,Sergio Pereira Almeida
Mendonca,Berenice Bilharinho
Fragoso,Maria Candida Barisson Villares
author_sort Costa,Marcia Helena Soares
title Glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in MEN1 syndrome without loss of heterozygosity at the 11q13 locus
title_short Glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in MEN1 syndrome without loss of heterozygosity at the 11q13 locus
title_full Glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in MEN1 syndrome without loss of heterozygosity at the 11q13 locus
title_fullStr Glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in MEN1 syndrome without loss of heterozygosity at the 11q13 locus
title_full_unstemmed Glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in MEN1 syndrome without loss of heterozygosity at the 11q13 locus
title_sort glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in men1 syndrome without loss of heterozygosity at the 11q13 locus
description BACKGROUND: The molecular mechanisms involved in the genesis of the adrenocortical lesions seen in MEN1 syndrome (ACL-MEN1) remain poorly understood; loss of heterozygosity at 11q13 and somatic mutations of MEN1 are not usually found in these lesions. Thus, additional genes must be involved in MEN1 adrenocortical disorders. Overexpression of the glucose-dependent insulinotropic peptide receptor has been shown to promote adrenocortical tumorigenesis in a mice model and has also been associated with ACTH-independent Cushing syndrome in humans. However, to our knowledge, the status of glucose-dependent insulinotropic peptide receptor expression in adrenocortical lesions in MEN1 has not been previously investigated. OBJECTIVE: To evaluate glucose-dependent insulinotropic peptide receptor expression in adrenocortical hyperplasia associated with MEN1 syndrome. MATERIALS/METHODS: Three adrenocortical tissue samples were obtained from patients with previously known MEN1 germline mutations and in whom the presence of a second molecular event (a new MEN1 somatic mutation or an 11q13 loss of heterozygosity) had been excluded. The expression of the glucose-dependent insulinotropic peptide receptor was quantified by qPCR using the DDCT method, and b-actin was used as an endogenous control. RESULTS: The median of glucose-dependent insulinotropic peptide receptor expression in the adrenocortical lesions associated with MEN1 syndrome was 2.6-fold (range 1.2 to 4.8) higher than the normal adrenal controls (p = 0.02). CONCLUSION: The current study represents the first investigation of glucose-dependent insulinotropic peptide receptor expression in adrenocortical lesions without 11q13 loss of heterozygosity in MEN1 syndrome patients. Although we studied a limited number of cases of MEN1 adrenocortical lesions retrospectively, our preliminary data suggest an involvement of glucose-dependent insulinotropic peptide receptor overexpression in the etiology of adrenocortical hyperplasia. New prospective studies will be able to clarify the exact role of the glucose-dependent insulinotropic peptide receptor in the molecular pathogenesis of MEN1 adrenocortical lesions.
publisher Faculdade de Medicina / USP
publishDate 2011
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000400002
work_keys_str_mv AT costamarciahelenasoares glucosedependentinsulinotropicpeptidereceptoroverexpressioninadrenocorticalhyperplasiainmen1syndromewithoutlossofheterozygosityatthe11q13locus
AT domenicesorahia glucosedependentinsulinotropicpeptidereceptoroverexpressioninadrenocorticalhyperplasiainmen1syndromewithoutlossofheterozygosityatthe11q13locus
AT toledorodrigoalmeida glucosedependentinsulinotropicpeptidereceptoroverexpressioninadrenocorticalhyperplasiainmen1syndromewithoutlossofheterozygosityatthe11q13locus
AT lourencojrdelmarmuniz glucosedependentinsulinotropicpeptidereceptoroverexpressioninadrenocorticalhyperplasiainmen1syndromewithoutlossofheterozygosityatthe11q13locus
AT latronicoanaclaudia glucosedependentinsulinotropicpeptidereceptoroverexpressioninadrenocorticalhyperplasiainmen1syndromewithoutlossofheterozygosityatthe11q13locus
AT pintoemiliamodolo glucosedependentinsulinotropicpeptidereceptoroverexpressioninadrenocorticalhyperplasiainmen1syndromewithoutlossofheterozygosityatthe11q13locus
AT toledosergiopereiraalmeida glucosedependentinsulinotropicpeptidereceptoroverexpressioninadrenocorticalhyperplasiainmen1syndromewithoutlossofheterozygosityatthe11q13locus
AT mendoncaberenicebilharinho glucosedependentinsulinotropicpeptidereceptoroverexpressioninadrenocorticalhyperplasiainmen1syndromewithoutlossofheterozygosityatthe11q13locus
AT fragosomariacandidabarissonvillares glucosedependentinsulinotropicpeptidereceptoroverexpressioninadrenocorticalhyperplasiainmen1syndromewithoutlossofheterozygosityatthe11q13locus
_version_ 1756432107482120192